American Portfolios Advisors Orchard Therapeutics PLC Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Orchard Therapeutics PLC stock. As of the latest transaction made, American Portfolios Advisors holds 6,375 shares of ORTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,375
Holding current value
$0
% of portfolio
0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$0.45 - $0.69 $2,868 - $4,398
6,375 New
6,375 $3.19 Million
Q3 2021

Mar 22, 2023
BUY
$2.24 - $4.29 $5,152 - $9,867
2,300 Added 36.08%
8,675 $20 Million
Q2 2021

Mar 22, 2023
BUY
$4.39 - $7.23 $12,292 - $20,244
2,800 Added 43.92%
9,175 $40.3 Million
Q1 2021

Mar 22, 2023
BUY
$4.39 - $9.08 $10,097 - $20,884
2,300 Added 36.08%
8,675 $63 Million
Q4 2020

Mar 22, 2023
SELL
$3.86 - $5.07 $5,211 - $6,844
-1,350 Reduced 21.18%
5,025 $21.7 Million
Q3 2020

Mar 22, 2023
SELL
$4.11 - $6.45 $1,438 - $2,257
-350 Reduced 5.49%
6,025 $24.8 Million
Q2 2020

Mar 24, 2023
BUY
$5.75 - $11.99 $5,175 - $10,791
900 Added 80.0%
2,025 $12.2 Million
Q1 2020

Mar 24, 2023
SELL
$5.65 - $15.71 $29,662 - $82,477
-5,250 Reduced 82.35%
1,125 $8.47 Million
Q4 2019

Mar 24, 2023
SELL
$10.15 - $15.58 $53,287 - $81,795
-5,250 Reduced 82.35%
1,125 $15.5 Million
Q2 2019

Mar 24, 2023
SELL
$13.2 - $20.63 $72,600 - $113,465
-5,500 Reduced 86.27%
875 $12.2 Million

Others Institutions Holding ORTX

# of Institutions
4
Shares Held
545K
Call Options Held
0
Put Options Held
0
View Full List

About Orchard Therapeutics plc

ORTX Quotes by TradingView
  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email